Your browser doesn't support javascript.
loading
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows.
Chapman, Lara S; Kelly, Ayano; Balay-Dustrude, Erin; Bekker, Charlotte; Berthelsen, Dorthe B; Ghosh, Nilasha; Gordon, Rachael A; Haas, Romi; Jones, Caitlin; Luquini, Andre; Weinbrecht-Mischkewitz, Max; Pickles, Tim; Saygin, Didem; Nielsen, Wils; Webers, Casper; Grosskleg, Shawna; Tugwell, Peter; D'Agostino, Maria Antonietta; Guillemin, Francis; March, Lyn.
Afiliación
  • Chapman LS; HEE/NIHR Clinical Doctoral Research Fellow, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK. Electronic address: L.Chapman1@leeds.ac.uk.
  • Kelly A; PhD student, Canberra Rheumatology, Department of Rheumatology, Canberra Hospital, and College of Health and Medicine, Australian National University, Australia.
  • Balay-Dustrude E; Pediatric Rheumatology Fellow, Seattle Children's Hospital, Department of Pediatrics, University of Washington, Seattle, WA, USA.
  • Bekker C; Assistant Professor, Department of Pharmacy, Radboudumc university medical center, the Netherlands.
  • Berthelsen DB; PhD student, Section for Biostatistics and Evidence-Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark; Department of Reh
  • Ghosh N; Assistant Professor, Hospital for Special Surgery/Weill Cornell Medical College, Cornell University, New York, USA.
  • Gordon RA; Rheumatology Fellow, University of Pittsburgh, Department of Medicine, Division of Rheumatology and Clinical Immunology, Pittsburgh, USA.
  • Haas R; Research Fellow, Musculoskeletal Health and Wiser Health Care Units, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia.
  • Jones C; Postdoctoral Research Associate, Sydney Musculoskeletal Health, Sydney School of Public Health & The Institute for Musculoskeletal Health, Sydney Local Health District and University of Sydney, Australia.
  • Luquini A; PhD student, Department of Experimental Medicine, Faculty of Medicine, University of British Columbia, Canada.
  • Weinbrecht-Mischkewitz M; Research Fellow, Section for Biostatistics and Evidence-Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Department of Internal Medicine, Rheumatology, Clinical Immunology and Osteology, Schlosspark-Klinik, University Medicine Berlin, Germany.
  • Pickles T; Health and Care Research Wales NIHR Doctoral Fellow, Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.
  • Saygin D; Assistant Professor, University of Pittsburgh Medical Center, Department of Medicine, Division of Rheumatology and Clinical Immunology, Pittsburgh, USA.
  • Nielsen W; PhD student, University of Toronto Lupus Clinic, Centre for Prognosis Studies, Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada.
  • Webers C; Postdoctoral Researcher, Department of Rheumatology, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Grosskleg S; Secretariat, Outcome Measures in Rheumatology (OMERACT), Toronto, Canada.
  • Tugwell P; Professor of Medicine and Epidemiology & Community Medicine, University of Ottawa, Ontario, Canada.
  • D'Agostino MA; Professor of Rheumatology, Università Cattolica del Sacro Cuore; Rheumatology UOC, Fondazione Policlinico Universitario Agostino Gemelli, IRCSS, Rome, Italy.
  • Guillemin F; Professor, INSPIIRE, Université de Lorraine, Inserm, Nancy, France.
  • March L; Professor, Department of Rheumatology, Royal North Shore Hospital and Kolling Institute, The University of Sydney, Australia.
Semin Arthritis Rheum ; 65: 152391, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38340612
ABSTRACT

OBJECTIVE:

To describe the evolution of the OMERACT Fellows Program (OM FP) and to evaluate the innovative changes implemented in the 2023 program.

METHODS:

The OM FP, the first of its kind in global rheumatology, was developed in 2000 to mentor early career researchers in methods and processes for reaching evidence-driven consensus for outcome measures in clinical studies. The OM FP has evolved through continuing iterations of face to face and online feedback. Key new features delivered in 2023 included e-learning modules, virtual introductory pre-meetings, increased networking with Patient Research Partners (PRPs), learning opportunities to give and receive personal feedback, ongoing performance feedback during the meeting from Fellow peers, PRPs, senior OMERACTers (members of the OMERACT community) and Emerging Leader mentors, involvement in pitching promotions, two-minute Lightning Talks in a plenary session and an embedded poster tour. An online survey was distributed after the meeting to evaluate the program.

RESULTS:

OM FP has included 208 fellows from 16 countries across 4 continents covering 47 different aspects of rheumatology outcomes since its inception. Over 50 % have remained engaged with OMERACT work. In 2023, 18 Fellows attended and 15 (83 %) completed the post-meeting survey. A dedicated OM FP was deemed important by all respondents, and 93 % would attend the meeting in future. The PRP/Fellow Connection Carousel and Lightning Talks were rated exceptional by 93 %. Key components to improve included clarification of expectations, overall workload, the Emerging Leaders Mentoring Program, and the content and duration of daily summary sessions.

CONCLUSION:

The innovations in the 2023 OM FP were well received by the majority of participants and supports early career rheumatology researchers to develop collaborations, skills and expertise in outcome measurement. Implementation of feedback from Fellows will enhance the program for future meetings, continuing to facilitate learning and succession planning within OMERACT.
Asunto(s)
Palabras clave
N/A

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Reumatología Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: Semin Arthritis Rheum Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Reumatología Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: Semin Arthritis Rheum Año: 2024 Tipo del documento: Article